Our Consortium

Investment Funds

AI-Pharma Investment Fund (AI-Pharma.Capital) is a hybrid investment fund focused on the AI in Pharma and Drug discovery sectors, backed by seasoned professionals who have been active in both the investment banking and AI for Drug Discovery industries for years, long before the sector was recognized as a serious prospect by the overwhelming majority of investors. The Fund structures its portfolio based on industry intelligence and analytics by the Pharma Division of Deep Knowledge Analytics.

Longevity FinTech is the longevity industry-focused UK financial technology company, aiming to provide white label AgeTech, FinTech and WealthTech solutions for financial institutions to be prepared for the Silver Tsunami Economy and adapt their Infrastructure to satisfy needs of the senior generation.

Longevity.Capital is a specialized Longevity-Focused Hedge Fund with enhanced liquidity that uses hybrid investment technologies to combine the profitability of venture funds with the liquidity of hedge funds, significantly de-risking the interests of LPs and providing the best and most promising Longevity companies with relevant amounts of investment. 

Analytical Subsidiaries

Deep Knowledge Analytics is a deep tech analytical agency using multidimensional algorithms to produce advanced industrial reports on DeepTech and frontier technologies. An online analytics platform with interactive visuals updated in real-time was released early this year.

It is an analytical subsidiary of Deep Knowledge Group, an international consortium of commercial and non-profit organizations focused on the synergetic convergence of DeepTech and Frontier Technologies (AI, Longevity, MedTech, FinTech, GovTech)

Aging Analytics Agency is the world’s premier provider of industry analytics on the topics of Longevity, Precision Preventive Medicine and Economics of Aging, and the convergence of technologies such as AI, Blockchain, Digital Health and their impact on the healthcare industry. Aging Analytics Agency is the only analytics company focused exclusively on the topics of Aging, Geroscience and Longevity. Founded in 2013, with headquarters in London, UK and branches in Europe, US and Canada, it began producing in-depth reports on Longevity long before it emerged as an industry.

 

Deep Pharma Intelligence (DPI) is a leading strategic and investment intelligence agency focused on the emerging markets in the Pharmaceutical, BioTech, and Healthcare Tech industries. 

DPI is producing regular analytical reports on major areas of high-potential in the pharmaceutical and healthcare industries, maintaining ratings of companies and governments based on their innovation potential and business activity in the BioTech space, and providing strategic consulting and investment intelligence services to top-tier clients.

Innovation Eye Limited is a new company jointly founded in March 2019 by Big Innovation Centre Limited and Deep Knowledge Analytics Ltd. to provide sophisticated market analytics, industry intelligence, comparative industry classification frameworks and benchmark case studies, developing advanced tools for analysis and visualization of technology and innovation ecosystems through reports, custom-made consultancy products and services, and dynamic interactive online IT-platforms.

The Pharma Division of Deep Knowledge Analytics is the leading analytical entity specifically focused on deep intelligence of the pharma industry and the AI for Drug Discovery sector. Its reports have been recognized by industry experts and executives as the dominant source of sophisticated industry analysis, pragmatic forecasting and tangible benchmarking on the AI in Pharma sector. The Pharma Division of Deep Knowledge Analytics currently serves as the main source of market intelligence and analytics for AI-Pharma, a specialized hybrid hedge fund.

The GovTech Division of Deep Knowledge Analytics focuses on producing sophisticated open-access and proprietary analytics the reveal factors driving the ongoing transformation of the global GovTech industry, main sectors to be changed, barriers to this process, and ways to overcome them.

NeuroTech Analytics specializes in the production of open-access and commercial comparative analytics on the full scope of the global NeuroTech industry, ranging from brain-computer interfaces to implant technologies, neurostimulation and neuromodulation, and neuroplasticity-increasing apps.

Non-Profit

Longevity.International is an online interactive database of longevity scientists, companies, and investors. This platform allows different stakeholders in the longevity industry to connect, network, research and analyze. On the next stage this platform will also employ cutting-edge data visualization software and a networking section where various stakeholders within the longevity industry can connect and collaborate, where longevity companies are matched with the right investors, and where scientists can make contributions.

 

Biogerontology Research Foundation is the UK’s charity focused on Longevity and on expediting the coming paradigm shift from disease treatment to personalized precision prevention. It was the main initial donor that provided financial and organisational support to Longevity International UK for the purpose of establishing the APPG for Longevity. It was also actively involved in the successful initiative of adding a new extension code for “ageing-related diseases” accepted in 2018 by the World Health Organization during the last revisions of its International Classification of Diseases framework.